X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql025-for-the-treatment-of-egfr-inhibitor-induced-acneiform-rash-302025647.html
https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql051-for-the-prophylaxis-of-chemotherapy-induced-diarrhea-301844368.html
https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql036-for-the-prophylaxis-of-capecitabine-induced-hand-foot-syndrome-301811098.html
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-presented-preclinical-data-for-oql025-and-oql06x-novel-therapeutics-for-egfr-inhibitor-induced-acneiform-rash-and-diarrhea-at-the-aacr-annual-meeting-301799697.html
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-announces-presentations-of-oql025-and-oql06x-at-the-aacr-annual-meeting-301772559.html
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-expands-part-2-of-the-nova-ii-phase-2-clinical-trial-to-china-and-india-301713733.html
https://www.clinicaltrialsarena.com/news/onquality-first-subject-hfsr-therapy/
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-annouces-the-enrollment-of-the-first-patient-in-part-2-of-the-nova-ii-phase-2-clinical-trial-301670904.html
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-to-have-two-abstracts-published-in-the-2022-asco-annual-meeting-proceedings-301556397.html
https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-to-present-preclinical-data-for-oql051-a-novel-chemotherapy-induced-diarrhea-therapeutic-at-aacr-301497324.html
Market Place
Share 
